Sarepta Therapeutics, Inc.
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2020 | — | -104.5% | -102.6% |
| FY2021 | — | -65.5% | -59.7% |
| FY2022 | — | -57.5% | -75.4% |
| FY2023 | — | -21.5% | -43.1% |
| FY2024 | — | 11.5% | 12.4% |
| FY2025 | 98.8% | -31.8% | -32.5% |
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2020 | — | -104.5% | -102.6% |
| FY2021 | — | -65.5% | -59.7% |
| FY2022 | — | -57.5% | -75.4% |
| FY2023 | — | -21.5% | -43.1% |
| FY2024 | — | 11.5% | 12.4% |
| FY2025 | 98.8% | -31.8% | -32.5% |